Developer docs
API playgroundTry for free, no card

Search company profiles

Bilim Pharmaceuticals

Full company profile

uuid000uz9n

Namestring
Bilim Pharmaceuticals
Legal namestring
Bilim İlaç Sanayii ve Ticaret Anonim Şirketi
Company typeenum
Private
Founded yearint
1953
Descriptiontext

Bilim Pharmaceuticals (legal name: Bilim İlaç Sanayii ve Ticaret Anonim Şirketi) is a 100% domestically owned Turkish pharmaceutical manufacturer founded in 1953 and headquartered in Beyoğlu, İstanbul. The company develops, manufactures, and markets generic equivalents of patent-expired originator medicines across nine therapeutic areas — antibiotics, respiratory, musculoskeletal, ophthalmology, endocrinology/metabolism, gastroenterology, urogenital, cardiovascular, and dermatology — operating from a portfolio of 480 licensed medicines of which approximately 200 are actively marketed. Manufacturing is performed across three sites: a 2008-commissioned Gebze facility designed to FDA standards producing solid, liquid, and semi-solid dosage forms; a 1998 Çerkezköy penicillin facility; and a 2019 Sterile Liquid Products facility approved by the Turkish Ministry of Health for solution and suspension Nebul Inhaler products. A USD 15 million R&D center operates with FDA-standard pilot production, QbD methodology, CTD-format registration capabilities, and 100+ scientists across formulation, analytical development, and clinical research. The company holds GMP, GLP, ISO 14001, ISO 27001, KVKK, PCI DSS, and CMMC Level 1 certifications, and was ranked 2nd in box ranking among 753 companies in the Turkish pharmaceutical market (2022 data) and 1st in prescription preference in its operating markets.

Bilim's revenue model is concentrated on one-time product sales of licensed pharmaceuticals, primarily through a domestic field force of nearly 1,000 employees organized in 8 specialty teams across 11 regions covering all 81 Turkish provinces. Customers are healthcare professionals (physicians across 14 specialties plus pharmacists) who dispense and prescribe the products to patients in Turkey's regulated pharmaceutical pricing environment. Internationally, the company exports through representative offices in Moldova (2007), Albania (2009), and UAE/Dubai (2022), supported by a global marketing team of approximately 300, with cumulative export revenue milestones progressing from USD 10 million (2006) to USD 55 million (2020) and over 1,200 product licenses in international markets. Bilim was recognized as the leading exporter among Turkish pharmaceutical companies in 2016 and operates contract manufacturing, technology-transfer, co-marketing, and joint-development agreements across 70+ countries. The firm maintains a group-company relationship with subsidiary Hüsnü Arsan İlaçları A.Ş. and supports an Orange Hour volunteer program that has touched nearly 80,000 people since 2005.

Short descriptiontext

Bilim Pharmaceuticals is a 100% domestically owned Turkish generic-drug manufacturer founded in 1953, producing 480 licensed medicines across nine therapeutic areas from three FDA-standard facilities and serving physicians, pharmacists, and patients in Turkey and 70+ export markets.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1,001–5,000
akta.pro rankint
HeadquartersIstanbul
HQ citystring
Istanbul
Markets served

Serves global market

Offices17 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
pharmaceutical manufacturing, generic medicines, prescription drugs, therapeutic areas, pharmaceutical R&D
Industry1 code
PRIMARYHLAIABAL
Generic Hospital & Institutional Products
NAICS code1 code
  • Pharmaceutical Preparation Manufacturing325412
SIC code1 code
  • Pharmaceutical Preparations2834
Product category
Generic Pharmaceuticals
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Pharmaceutical Product Sales
TypeOne Time License
Description

Bilim Pharmaceuticals generates revenue through the sale of licensed pharmaceutical products. The company has 480 licensed medicines with approximately 200 products actively on the market, covering therapeutic areas including antibiotics, respiratory system, musculoskeletal system, ophthalmology, endocrinology, gastroenterology, urogenital system, cardiovascular system, and dermatology.

bilimilac.com.tr
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Supply Chain, Personnel, Operations, Technology or R&D, Marketing or Sales
GTM typeB2B and B2C
B2B and B2C
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

Bilim Pharmaceuticals manufactures, licenses, and markets a broad portfolio of branded generic and prescription medicines across multiple therapeutic areas, including antibiotics, respiratory, cardiovascular, musculoskeletal, ophthalmology, endocrinology, gastroenterology, urogenital, and dermatology. The company operates domestic manufacturing facilities and an in-house R&D center, and sells both in Turkey and through international exports.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • Ranked 2nd in box ranking among 753 companies in Turkish pharmaceutical market (2022)
+3 more records
Product overview1 text field

Bilim Pharmaceuticals is a 100% domestically-owned Turkish pharmaceutical company founded in 1953. It operates as a single unified product portfolio company offering 480 licensed medicines, with approximately 200 actively marketed products across Turkey. The company produces pharmaceutical products across multiple therapeutic areas including antibiotics, respiratory system medicines, musculoskeletal system products, ophthalmology, endocrinology, gastroenterology, urogenital system, cardiovascular system, and dermatology. The product portfolio is supported by FDA-standard R&D facilities and three production facilities (Gebze, Çerkezköy Penicillin, and Sterile Liquid), with the R&D center developing generic versions of patent-expired original medicines.

Product and service5 records
1Antibiotic pharmaceutical portfolio
CategoryAnti-infectives / Antibiotics
Description

Branded generic and prescription antibacterial medicines produced primarily at the Çerkezköy penicillin facility, distributed to wholesalers, hospitals, and pharmacies in Turkey and export markets.

2Respiratory pharmaceutical portfolio
CategoryRespiratory Therapeutics
Description

Prescription and OTC respiratory medicines marketed to physicians, pharmacies, and hospitals across Turkey and selected export markets.

3Cardiovascular pharmaceutical portfolio
CategoryCardiovascular Therapeutics
Description

Cardiovascular prescription drugs supplied to Turkish wholesalers, hospitals, and reimbursement systems, and exported through international partners.

4Sterile liquid pharmaceutical products
CategorySterile Dosage Manufacturing
Description

Sterile liquid (injectable and liquid) dosage form pharmaceuticals manufactured at Bilim's sterile liquid facility, marketed across multiple therapeutic areas for hospital and retail channel use.

5Musculoskeletal, ophthalmology, endocrinology, gastroenterology, urogenital, and dermatology portfolios
CategorySpecialty Pharmaceuticals
Description

Prescription specialty pharmaceutical product lines spanning musculoskeletal, ophthalmology, endocrinology, gastroenterology, urogenital, and dermatology indications, sold through Turkish and international channels.

Scale indicator15 records

Each record includes

Type, Value, Description, Source

Partnership2 partners
Strategic tierCoreTypeChannel Partner/ Reseller/ DistributorAnnounced on1998-01-01
Description

Contract manufacturing for regulated and non-regulated markets, technology transfer agreements, co-marketing agreements, and joint product development partnerships in 70+ countries. Over 1,200 product licenses in international markets with marketing team of 300 people globally.

2Hüsnü Arsan İlaçları A.Ş.
Strategic tierCoreTypeOthers
Description

Hüsnü Arsan İlaçları A.Ş. is Bilim Pharmaceuticals' group company (topluluk şirketi). Both companies share pharmacovigilance activities and the company contact form covers products from both Bilim İlaç San ve Tic. A.Ş. and Hüsnü Arsan İlaçları A.Ş.

bilimilac.com.tr
Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Turkish generic manufacturer with broad multi-therapeutic portfolio and growing export presence; competes with Bilim domestically and in regional export markets.

TypeBroad incumbent
Description

European-based generics and specialty pharma company with strong presence in European and CIS markets that overlap with Bilim's regional export channels.

TypeBroad incumbent
Description

World's largest generic drug manufacturer with a broad specialty, generic, and biosimilar portfolio; directly comparable to Bilim in therapeutic-area breadth and international reach.

TypeBroad incumbent
Description

Large Indian generic manufacturer with vertically integrated API and finished-dose operations; competes with Bilim in international tenders and contract manufacturing markets.

5Hüsnü Arsan İlaçları
TypeDirect peer
Description

Bilim's group-affiliated Turkish pharmaceutical company sharing pharmacovigilance and certain operations; relevant as a directly comparable Turkish domestic pharma peer in same group structure.

6Nobel İlaç
TypeDirect peer
Description

Another leading Turkish generic pharmaceutical manufacturer with multi-category product portfolio and overseas expansion; competes head-to-head with Bilim in domestic market rankings.

7Sandoz (Novartis)
TypeBroad incumbent
Description

Global generics leader producing prescription and specialty generics across all major therapeutic areas; competes with Bilim in Turkey and across Bilim's 70+ international markets.

TypeBroad incumbent
Description

Global generics and specialty company combining legacy Mylan and Upjohn; competes with Bilim on generic prescription drugs in Turkey and across its 70-country international footprint.

TypeDirect peer
Description

Turkey's largest domestic pharmaceutical company and Bilim's closest domestic competitor; both focus on generic drug manufacturing, broad therapeutic-area portfolios, and operate nationwide field sales organisations in Turkey.

TypeDirect peer
Description

Major Turkish pharma group with branded generics across multiple therapeutic areas including respiratory and dermatology; overlaps with Bilim's product portfolio and Turkish distribution footprint.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers2 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature2 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Subsidiaries1 record

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance9 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Bilim Pharmaceuticals

Generic Pharmaceuticalsbilimilac.com.tr

Bilim Pharmaceuticals is a 100% domestically owned Turkish generic-drug manufacturer founded in 1953, producing 480 licensed medicines across nine therapeutic areas from three FDA-standard facilities and serving physicians, pharmacists, and patients in Turkey and 70+ export markets.

What Bilim Pharmaceuticals does

Bilim Pharmaceuticals (legal name: Bilim İlaç Sanayii ve Ticaret Anonim Şirketi) is a 100% domestically owned Turkish pharmaceutical manufacturer founded in 1953 and headquartered in Beyoğlu, İstanbul. The company develops, manufactures, and markets generic equivalents of patent-expired originator medicines across nine therapeutic areas — antibiotics, respiratory, musculoskeletal, ophthalmology, endocrinology/metabolism, gastroenterology, urogenital, cardiovascular, and dermatology — operating from a portfolio of 480 licensed medicines of which approximately 200 are actively marketed. Manufacturing is performed across three sites: a 2008-commissioned Gebze facility designed to FDA standards producing solid, liquid, and semi-solid dosage forms; a 1998 Çerkezköy penicillin facility; and a 2019 Sterile Liquid Products facility approved by the Turkish Ministry of Health for solution and suspension Nebul Inhaler products. A USD 15 million R&D center operates with FDA-standard pilot production, QbD methodology, CTD-format registration capabilities, and 100+ scientists across formulation, analytical development, and clinical research. The company holds GMP, GLP, ISO 14001, ISO 27001, KVKK, PCI DSS, and CMMC Level 1 certifications, and was ranked 2nd in box ranking among 753 companies in the Turkish pharmaceutical market (2022 data) and 1st in prescription preference in its operating markets.

Bilim's revenue model is concentrated on one-time product sales of licensed pharmaceuticals, primarily through a domestic field force of nearly 1,000 employees organized in 8 specialty teams across 11 regions covering all 81 Turkish provinces. Customers are healthcare professionals (physicians across 14 specialties plus pharmacists) who dispense and prescribe the products to patients in Turkey's regulated pharmaceutical pricing environment. Internationally, the company exports through representative offices in Moldova (2007), Albania (2009), and UAE/Dubai (2022), supported by a global marketing team of approximately 300, with cumulative export revenue milestones progressing from USD 10 million (2006) to USD 55 million (2020) and over 1,200 product licenses in international markets. Bilim was recognized as the leading exporter among Turkish pharmaceutical companies in 2016 and operates contract manufacturing, technology-transfer, co-marketing, and joint-development agreements across 70+ countries. The firm maintains a group-company relationship with subsidiary Hüsnü Arsan İlaçları A.Ş. and supports an Orange Hour volunteer program that has touched nearly 80,000 people since 2005.

Bilim Pharmaceuticals firmographics

Firmographics
Name
Bilim Pharmaceuticals
Legal name
Bilim İlaç Sanayii ve Ticaret Anonim Şirketi
Website
https://bilimilac.com.tr
Company type
Private
Founded year
1953
Operating status
Operating
Headcount range
1,001–5,000 employees
Short description
Bilim Pharmaceuticals is a 100% domestically owned Turkish generic-drug manufacturer founded in 1953, producing 480 licensed medicines across nine therapeutic areas from three FDA-standard facilities and serving physicians, pharmacists, and patients in Turkey and 70+ export markets.
Ownership category
akta.pro rank

Bilim Pharmaceuticals industry classification

Industry
Product category
Generic Pharmaceuticals
NAICS
Pharmaceutical Preparation Manufacturing (325412)
SIC
Pharmaceutical Preparations (2834)
akta.pro industry
PRIMARYHLAIABAL
Generic Hospital & Institutional Products

Keywords

  • Pharmaceutical manufacturing
  • Generic medicines
  • Prescription drugs
  • Therapeutic areas
  • Pharmaceutical R&D

Where Bilim Pharmaceuticals is headquartered

Location

Headquarters

HQ city
Istanbul

Offices17 records

Markets served

Bilim Pharmaceuticals business model

Business model
GTM type
B2B and B2C
Offering type
Hardware or Manufacturing
Cost components
Supply Chain, Personnel, Operations, Technology or R&D, Marketing or Sales

Revenue model

  1. Pharmaceutical Product Sales: Bilim Pharmaceuticals generates revenue through the sale of licensed pharmaceutical products. The company has 480 licensed medicines with approximately 200 products actively on the market, covering therapeutic areas including antibiotics, respiratory system, musculoskeletal system, ophthalmology, endocrinology, gastroenterology, urogenital system, cardiovascular system, and dermatology.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels4 records

Bilim Pharmaceuticals product offering

Product offering

Core offering

Bilim Pharmaceuticals manufactures, licenses, and markets a broad portfolio of branded generic and prescription medicines across multiple therapeutic areas, including antibiotics, respiratory, cardiovascular, musculoskeletal, ophthalmology, endocrinology, gastroenterology, urogenital, and dermatology. The company operates domestic manufacturing facilities and an in-house R&D center, and sells both in Turkey and through international exports.

Product overview

Bilim Pharmaceuticals is a 100% domestically-owned Turkish pharmaceutical company founded in 1953. It operates as a single unified product portfolio company offering 480 licensed medicines, with approximately 200 actively marketed products across Turkey. The company produces pharmaceutical products across multiple therapeutic areas including antibiotics, respiratory system medicines, musculoskeletal system products, ophthalmology, endocrinology, gastroenterology, urogenital system, cardiovascular system, and dermatology. The product portfolio is supported by FDA-standard R&D facilities and three production facilities (Gebze, Çerkezköy Penicillin, and Sterile Liquid), with the R&D center developing generic versions of patent-expired original medicines.

Differentiator

Problem solved

Functional benefit

Products and services

  • Antibiotic pharmaceutical portfolio Branded generic and prescription antibacterial medicines produced primarily at the Çerkezköy penicillin facility, distributed to wholesalers, hospitals, and pharmacies in Turkey and export markets.
  • Respiratory pharmaceutical portfolio Prescription and OTC respiratory medicines marketed to physicians, pharmacies, and hospitals across Turkey and selected export markets.
  • Cardiovascular pharmaceutical portfolio Cardiovascular prescription drugs supplied to Turkish wholesalers, hospitals, and reimbursement systems, and exported through international partners.
  • Sterile liquid pharmaceutical products Sterile liquid (injectable and liquid) dosage form pharmaceuticals manufactured at Bilim's sterile liquid facility, marketed across multiple therapeutic areas for hospital and retail channel use.
  • Musculoskeletal, ophthalmology, endocrinology, gastroenterology, urogenital, and dermatology portfolios Prescription specialty pharmaceutical product lines spanning musculoskeletal, ophthalmology, endocrinology, gastroenterology, urogenital, and dermatology indications, sold through Turkish and international channels.

Quantifiable outcome

  • Ranked 2nd in box ranking among 753 companies in Turkish pharmaceutical market (2022)
  • +3 more outcomes

Companies that use Bilim Pharmaceuticals

Customer profile

Named customers2 records

Segments3 records

Ideal customer profiles2 records

Bilim Pharmaceuticals technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature2 records

Bilim Pharmaceuticals partnerships and signals

Strategic signal

Partnerships

Two partnerships are on record, tiered core.

  • International Distribution PartnerscoreChannel Partner/ Reseller/ Distributor · 1 January 1998Contract manufacturing for regulated and non-regulated markets, technology transfer agreements, co-marketing agreements, and joint product development partnerships in 70+ countries. Over 1,200 product licenses in international markets with marketing team of 300 people globally.
  • Hüsnü Arsan İlaçları A.Ş.coreOthersHüsnü Arsan İlaçları A.Ş. is Bilim Pharmaceuticals' group company (topluluk şirketi). Both companies share pharmacovigilance activities and the company contact form covers products from both Bilim İlaç San ve Tic. A.Ş. and Hüsnü Arsan İlaçları A.Ş.

Scale indicators15 records

Recent moves7 records

Expansion highlights6 records

Bilim Pharmaceuticals competitors and assessment

Company assessment

Direct peers

  • Sanovel Pharmaceuticals: Turkish generic manufacturer with broad multi-therapeutic portfolio and growing export presence; competes with Bilim domestically and in regional export markets.
  • Hüsnü Arsan İlaçları: Bilim's group-affiliated Turkish pharmaceutical company sharing pharmacovigilance and certain operations; relevant as a directly comparable Turkish domestic pharma peer in same group structure.
  • Nobel İlaç: Another leading Turkish generic pharmaceutical manufacturer with multi-category product portfolio and overseas expansion; competes head-to-head with Bilim in domestic market rankings.
  • Abdi İbrahim: Turkey's largest domestic pharmaceutical company and Bilim's closest domestic competitor; both focus on generic drug manufacturing, broad therapeutic-area portfolios, and operate nationwide field sales organisations in Turkey.
  • Eczacıbaşı (EIP): Major Turkish pharma group with branded generics across multiple therapeutic areas including respiratory and dermatology; overlaps with Bilim's product portfolio and Turkish distribution footprint.

Broad incumbents

  • Stada Arzneimittel: European-based generics and specialty pharma company with strong presence in European and CIS markets that overlap with Bilim's regional export channels.
  • Teva Pharmaceutical Industries: World's largest generic drug manufacturer with a broad specialty, generic, and biosimilar portfolio; directly comparable to Bilim in therapeutic-area breadth and international reach.
  • Aurobindo Pharma: Large Indian generic manufacturer with vertically integrated API and finished-dose operations; competes with Bilim in international tenders and contract manufacturing markets.
  • Sandoz (Novartis): Global generics leader producing prescription and specialty generics across all major therapeutic areas; competes with Bilim in Turkey and across Bilim's 70+ international markets.
  • Viatris: Global generics and specialty company combining legacy Mylan and Upjohn; competes with Bilim on generic prescription drugs in Turkey and across its 70-country international footprint.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

Bilim Pharmaceuticals social profiles

Digital presence

Bilim Pharmaceuticals compliance and trust

Trust signal

Compliance9 records

Bilim Pharmaceuticals financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Bilim Pharmaceuticals leadership team

Management profile

Number of profiles

Bilim Pharmaceuticals subsidiaries and ownership

Company hierarchy

Subsidiaries1 record

Bilim Pharmaceuticals funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Bilim Pharmaceuticals M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Bilim Pharmaceuticals

What does Bilim Pharmaceuticals do?

Bilim Pharmaceuticals manufactures, licenses, and markets a broad portfolio of branded generic and prescription medicines across multiple therapeutic areas, including antibiotics, respiratory, cardiovascular, musculoskeletal, ophthalmology, endocrinology, gastroenterology, urogenital, and dermatology. The company operates domestic manufacturing facilities and an in-house R&D center, and sells both in Turkey and through international exports.

Is Bilim Pharmaceuticals a public or private company?

Bilim Pharmaceuticals is a private company. It is classified as family owned and is currently operating.

When was Bilim Pharmaceuticals founded?

Bilim Pharmaceuticals was founded in 1953. It employs 1,001 to 5,000 people.

Where is Bilim Pharmaceuticals based?

Bilim Pharmaceuticals is headquartered in Istanbul.

How does Bilim Pharmaceuticals make money?

One revenue line is on record: pharmaceutical Product Sales.

Who are Bilim Pharmaceuticals's main competitors?

Direct peers on record are Sanovel Pharmaceuticals, Hüsnü Arsan İlaçları, Nobel İlaç, Abdi İbrahim and Eczacıbaşı (EIP). Broad incumbents are Stada Arzneimittel, Teva Pharmaceutical Industries, Aurobindo Pharma, Sandoz (Novartis) and Viatris.

Does Bilim Pharmaceuticals have an API?

No public API is recorded for Bilim Pharmaceuticals.

What industry is Bilim Pharmaceuticals in?

Bilim Pharmaceuticals's product category is Generic Pharmaceuticals. Its primary akta.pro industry code is HLAIABAL, Generic Hospital & Institutional Products. Its NAICS code is 325412 and its SIC code is 2834.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales